About Johns Hopkins
Johns Hopkins University

Recent news from The Johns Hopkins University

This section contains regularly updated highlights of the news from around The Johns Hopkins University. Links to the complete news reports from the nine schools, the Applied Physics Laboratory and other centers and institutes are to the left, as are links to help news media contact the Johns Hopkins communications offices.

 

Reducing Brain Activity Improves Memory After Cognitive Decline, Johns Hopkins Team Finds

A study led by Michela Gallagher of The Johns Hopkins University and published in the May 10 issue of the journal Neuron suggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer’s disease.

Drug Improves Brain Function in Condition that Leads to Alzheimer’s

An existing anti-seizure drug improves memory and brain function in adults with a form of cognitive impairment that often leads to full-blown Alzheimer’s disease, according to a study led by neuroscientist Michela Gallagher of The Johns Hopkins University. The findings raise the possibility that doctors will someday be able to use the drug, levetiracetam, already approved for use in epilepsy patients, to slow the abnormal loss of brain function in some aging patients before their condition becomes Alzheimer’s.

events calendar
click to view events calendar
browse Johns Hopkins A-Z
click to browse
on the web
  • click for hopkins on Facebook
  • click for hopkins on Twitter
  • click for hopkins on YouTube
  • click for hopkins music